0001767473-20-000002.txt : 20200528 0001767473-20-000002.hdr.sgml : 20200528 20200528173031 ACCESSION NUMBER: 0001767473-20-000002 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b ITEM INFORMATION: Investment Company Act Section 3(c) ITEM INFORMATION: Section 3(c)(7) FILED AS OF DATE: 20200528 DATE AS OF CHANGE: 20200528 EFFECTIVENESS DATE: 20200528 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Invesco Life Sciences Fund, LP CENTRAL INDEX KEY: 0001767473 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-332495 FILM NUMBER: 20922479 BUSINESS ADDRESS: STREET 1: 1555 PEACHTREE STREET NE CITY: ATLANTA STATE: GA ZIP: 30309 BUSINESS PHONE: 404-895-0896 MAIL ADDRESS: STREET 1: 1555 PEACHTREE STREET NE CITY: ATLANTA STATE: GA ZIP: 30309 FORMER COMPANY: FORMER CONFORMED NAME: OFI Global: Life Sciences Fund, LP DATE OF NAME CHANGE: 20190208 D/A 1 primary_doc.xml X0708 D/A LIVE 0001767473 Invesco Life Sciences Fund, LP 1555 PEACHTREE STREET NE ATLANTA GA GEORGIA 30309 404-895-0896 DELAWARE OFI Global: Life Sciences Fund, LP Limited Partnership true 2019 na Invesco Global Funds GP, LLC 1555 Peachtree Street NE Suite 1800 Atlanta GA GEORGIA 30309 Promoter General Partner na Invesco Advisers, Inc. 1555 Peachtree Street NE Suite 1800 Atlanta GA GEORGIA 30309 Promoter Investment Manager Leslie A Schmidt 1555 Peachtree Street NE Suite 1800 Atlanta GA GEORGIA 30309 Executive Officer Senior Vice President Pooled Investment Fund Hedge Fund false Decline to Disclose 06b 3C 3C.7 true 0001767473-19-000004 true true true true Limited Partnership Interests false 250000 Invesco Distributors, Inc. 7369 None None 11 Greenway Plaza Suite 1100 Houston TX TEXAS 77046 All States false Indefinite 0 Indefinite Fund Terminated as of May 28, 2020, remaining sold amount is $0 false 0 0 0 The person listed in Item 12 does not receive any finder's fees, sales commissions, remuneration or other distribution fees from their sales of the Issuer's securities. 0 true Certain persons named in Item 3 or affiliates thereof may receive payments deemed to be made from the proceeds of the offering, including management fees. The amount of such payments cannot be estimated at this time. false Invesco Life Sciences Fund, LP /S/ Leslie A. Schmidt Leslie A Schmidt Senior Vice President 2020-05-28